Rhupus Syndrome With Multiple Drug Intolerances Managed by Reduced-dose Rituximab and Adjunctive Molecular Hydrogen Therapy: A Case Report.
- DOI
- 10.21873/invivo.14221
- Published
- 2026 Jan-Feb
- Container
- In vivo (Athens, Greece)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.21873/invivo.14221,
title = {Rhupus Syndrome With Multiple Drug Intolerances Managed by Reduced-dose Rituximab and Adjunctive Molecular Hydrogen Therapy: A Case Report.},
author = {Tsai HL and Lu JW and Ho YJ and Lui SW and Hsieh TY and Wang KY and Liu FC},
year = {2026},
journal = {In vivo (Athens, Greece)},
doi = {10.21873/invivo.14221},
url = {https://doi.org/10.21873/invivo.14221}
}RIS
TY - JOUR TI - Rhupus Syndrome With Multiple Drug Intolerances Managed by Reduced-dose Rituximab and Adjunctive Molecular Hydrogen Therapy: A Case Report. AU - Tsai HL AU - Lu JW AU - Ho YJ AU - Lui SW AU - Hsieh TY AU - Wang KY AU - Liu FC PY - 2026 JO - In vivo (Athens, Greece) DO - 10.21873/invivo.14221 UR - https://doi.org/10.21873/invivo.14221 ER -
APA
HL, T., JW, L., YJ, H., SW, L., TY, H., KY, W., & FC, L. (2026). Rhupus Syndrome With Multiple Drug Intolerances Managed by Reduced-dose Rituximab and Adjunctive Molecular Hydrogen Therapy: A Case Report.. In vivo (Athens, Greece). https://doi.org/10.21873/invivo.14221
Source records
- pubmed · retrieved 2026-09-26T15:49:54.368Z